Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis
Clinical & Experimental Immunology, Volume 0, Issue 0, Page
, September 2003.
Summary Coeliac disease is characterized by immunoglobulin-A (IgA)-class autoantibodies targeted against transglutaminase 2 (TG2), a multi-functional protein also with a role in angiogenesis. These antibodies are present in patient serum but are also ... (Source: Clinical and Experimental Immunology)
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2249.2008.03600.x?ai=ry&mi=5zfmi&af=R
